A study to observation patients with cancer who develop fever on chemotherapy due to low white cell count
Not Applicable
- Conditions
- Health Condition 1: D701- Agranulocytosis secondary to cancer chemotherapyHealth Condition 2: R509- Fever, unspecifiedHealth Condition 3: D709- Neutropenia, unspecified
- Registration Number
- CTRI/2021/09/036930
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. Subjects with all age group will be included for the study.
b. Receiving chemotherapy for newly diagnosed or relapsed malignancy.
c. Febrile neutropenia defined as fever (temperature >100.4 F on two occasions within a 12 hour period or 101°F once) during neutropenia (absolute neutrophil count < 500 x 109 cells/L or absolute neutrophil count <1000 x 109 cells/L and falling)
Exclusion Criteria
a. Non-chemotherapy related febrile neutropenia.
b. Fever due to underlying malignancy
c. Non neutropenic fever
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method